Judge OKs $264M Deal Ending Mylan EpiPen Price-Hike Suit
By Jonathan Capriel · March 14, 2022, 9:01 PM EDT
A Kansas federal court has preliminarily approved a $264 million deal that would end claims that Mylan colluded with Pfizer Inc. to obstruct generic versions of the EpiPen, the emergency drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login